Search Results - "Castells, LLuís"
-
1
Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial
Published in Journal of hepatology (2003)“…Background/Aims: The efficacy and safety of rifaximin in comparison with lactitol in the treatment of acute hepatic encephalopathy was assessed in a…”
Get full text
Journal Article -
2
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study
Published in Transplant international (01-10-2017)“…Direct-acting antiviral agents (DAA) combining daclatasvir (DCV) have reported good outcomes in the recurrence of hepatitis C virus (HCV) infection after liver…”
Get more information
Journal Article -
3
Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
Published in Journal of hepatology (01-07-2005)“…The efficacy and safety of treatment with pegylated interferon α-2b (Peg-Intron,™ 1.5 μg/kg) and ribavirin (400–800 mg) in the acute phase of recurrent HCV…”
Get full text
Journal Article -
4
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
Published in Hepatology (Baltimore, Md.) (01-01-2000)“…The aim of this randomized controlled trial was to assess the efficacy of interferon alfa–2b (IFN) for the treatment of advanced hepatocellular carcinoma…”
Get full text
Journal Article -
5
The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition
Published in Journal of hepatology (01-07-2018)“…[Display omitted] •After the approval of DAAs, post-liver transplant survival has significantly increased.•The improved survival of LT recipients is exclusive…”
Get full text
Journal Article -
6
Immune‐related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors
Published in Liver international (01-08-2020)“…Background & Aims Check point inhibitors (CPI) have improved survival of oncology patients but adverse effects that mimic autoimmune disorders have been…”
Get full text
Journal Article -
7
Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation
Published in Hepatology (Baltimore, Md.) (01-05-2015)“…Recurrent hepatitis C virus (HCV) infection after liver transplantation (LT) is associated with accelerated progression of liver disease, frequently leading to…”
Get full text
Journal Article -
8
COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management
Published in Transplantation (01-01-2021)“…BACKGROUND:The epidemiological and clinical characteristics of solid organ transplant (SOT) patients during the severe acute respiratory syndrome coronavirus 2…”
Get full text
Journal Article -
9
Reconciling short‐term clinical and immunological outcomes of SARS‐CoV‐2 vaccination in solid organ transplant recipients
Published in American journal of transplantation (01-02-2022)Get full text
Journal Article -
10
Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation
Published in Journal of hepatology (01-12-2017)“…[Display omitted] •Antiviral therapy with direct-acting antivirals is safe and effective in patients awaiting liver transplantation.•Baseline liver function…”
Get full text
Journal Article -
11
Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection
Published in PloS one (28-07-2014)“…Acute and chronic hepatitis E have been associated with high mortality and development of cirrhosis, particularly in solid-organ recipients and patients…”
Get full text
Journal Article -
12
Frailty and sarcopenia in patients with acute-on-chronic liver failure: Assessment and risk in the liver transplant setting
Published in Annals of hepatology (01-09-2024)“…Frailty and sarcopenia are well-recognized factors related to worse outcomes in patients with cirrhosis, including liver transplant (LT) candidates…”
Get full text
Journal Article -
13
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end‐stage liver disease: Analysis of data from the Hepa‐C registry
Published in Hepatology (Baltimore, Md.) (01-06-2017)“…Direct‐acting antiviral agents (DAAs) are highly effective and well tolerated in patients with chronic hepatitis C virus infection, including those with…”
Get full text
Journal Article -
14
Changes in humoral immune response after SARS‐CoV‐2 infection in liver transplant recipients compared to immunocompetent patients
Published in American journal of transplantation (01-08-2021)“…The protective capacity and duration of humoral immunity after SARS‐CoV‐2 infection are not yet understood in solid organ transplant recipients. A prospective…”
Get full text
Journal Article -
15
Role of SARS-CoV-2-specific memory B cells promoting immune protection after booster vaccination in solid organ transplantation
Published in Frontiers in immunology (08-10-2024)“…Solid organ transplant (SOT) recipients display weak seroconversion and neutralizing antibody (NAb) responses after severe acute respiratory syndrome…”
Get full text
Journal Article -
16
Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy
Published in Annals of hepatology (01-05-2022)“…Spontaneous portosystemic shunts (SPSS) are a common cause of recurrent hepatic encephalopathy (HE). Shunt occlusion is an effective and safe procedure when…”
Get full text
Journal Article -
17
Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study)
Published in Microbiology spectrum (23-02-2022)“…Isavuconazole (ISA) is an alternative treatment for Aspergillus spp. and other fungal infections, but evidence regarding its use in solid organ transplant…”
Get full text
Journal Article -
18
Routine Bile Culture From Liver Donors as Screening of Donor‐Transmitted Infections in Liver Transplantation
Published in Liver transplantation (01-09-2020)“…Bacterial infections are an important threat in the early post–liver transplantation period. Donor‐transmitted infections, although rare, can have high…”
Get full text
Journal Article -
19
COVID-19 in liver transplant recipients: preliminary data from the ELITA/ELTR registry
Published in The lancet. Gastroenterology & hepatology (01-08-2020)Get more information
Journal Article -
20
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions
Published in European radiology (01-03-2008)“…A multicenter study has been employed to evaluate the diagnostic efficacy of magnetic resonance imaging (MRI) using the new liver-specific contrast agent…”
Get full text
Journal Article